494 related articles for article (PubMed ID: 9543401)
1. A close look at fenfluramine and dexfenfluramine.
Vivero LE; Anderson PO; Clark RF
J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
[TBL] [Abstract][Full Text] [Related]
2. Anesthetic considerations for the new antiobesity medications.
Jeffers LA
AANA J; 1996 Dec; 64(6):541-4. PubMed ID: 9204789
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE
N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087
[TBL] [Abstract][Full Text] [Related]
4. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
[TBL] [Abstract][Full Text] [Related]
5. Anorexigen-induced cardiac valvulopathy and female gender.
Naqvi TZ; Gross SB
Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dexfenfluramine in a weight loss program for obese infertile women.
Galletly C; Clark A; Tomlinson L
Int J Eat Disord; 1996 Mar; 19(2):209-12. PubMed ID: 8932560
[TBL] [Abstract][Full Text] [Related]
7. Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.
Ryan DH; Bray GA; Helmcke F; Sander G; Volaufova J; Greenway F; Subramaniam P; Glancy DL
Obes Res; 1999 Jul; 7(4):313-22. PubMed ID: 10440587
[TBL] [Abstract][Full Text] [Related]
8. [A multicenter open study of dexfenfluramine in Italy. The efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. The DIMOS Group].
Enzi G
Ter Arkh; 1997; 69(5):71-5. PubMed ID: 9235665
[TBL] [Abstract][Full Text] [Related]
9. Diet drugs and cardiac valvulopathy: a survey of dental patients.
Rudin R; Carpenter W
J Calif Dent Assoc; 2000 Dec; 28(12):955-9. PubMed ID: 11323951
[TBL] [Abstract][Full Text] [Related]
10. Dexfenfluramine.
Spollett G
Lippincotts Prim Care Pract; 1997; 1(3):320-3. PubMed ID: 9238953
[No Abstract] [Full Text] [Related]
11. Dexfenfluramine hydrochloride: an anorexigenic agent.
Bever KA; Perry PJ
Am J Health Syst Pharm; 1997 Sep; 54(18):2059-72. PubMed ID: 9377205
[TBL] [Abstract][Full Text] [Related]
12. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].
Héraïef E
Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531
[TBL] [Abstract][Full Text] [Related]
13. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.
Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL
JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938
[TBL] [Abstract][Full Text] [Related]
14. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
Davis R; Faulds D
Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819
[TBL] [Abstract][Full Text] [Related]
15. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine.
Kancherla MK; Salti HI; Mulderink TA; Parker M; Bonow RO; Mehlman DJ
Am J Cardiol; 1999 Dec; 84(11):1335-8. PubMed ID: 10614800
[TBL] [Abstract][Full Text] [Related]
17. Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study.
Palmieri V; Arnett DK; Roman MJ; Liu JE; Bella JN; Oberman A; Kitzman DW; Hopkins PN; Morgan D; de Simone G; Devereux RB
Am J Med; 2002 Jun; 112(9):710-5. PubMed ID: 12079711
[TBL] [Abstract][Full Text] [Related]
18. Anorectic therapy and valvular heart disease: a reappraisal.
Silvestry FE; St John Sutton M
Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
[No Abstract] [Full Text] [Related]
19. Prolonged weight loss with dexfenfluramine treatment in obese patients.
Finer N; Craddock D; Lavielle R; Keen H
Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
[TBL] [Abstract][Full Text] [Related]
20. New treatment for obesity: dexfenfluramine (Redux).
Bihm B
Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
